Northern Trust Corp Galapagos Nv Transaction History

Northern Trust Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$52.17 - $70.2 $328,671 - $442,260	-6,300 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$68.86 - $83.34 $43,863 - $53,087	-637 Reduced 9.18%	6,300 $435,000
Q1 2021 May 12, 2021	SELL	$76.15 - $111.94 $395,827 - $581,864	-5,198 Reduced 42.83%	6,937 $536,000
Q4 2020 Feb 11, 2021	BUY	$96.85 - $148.25 $31,185 - $47,736	322 Added 2.73%	12,135 $1.2 Million
Q3 2020 Nov 16, 2020	SELL	$122.47 - $213.56 $513,394 - $895,243	-4,192 Reduced 26.19%	11,813 $1.68 Million
Q2 2020 Aug 14, 2020	SELL	$185.52 - $231.25 $1.01 Million - $1.25 Million	-5,422 Reduced 25.3%	16,005 $3.16 Million
Q1 2020 May 14, 2020	BUY	$143.0 - $274.03 $972,543 - $1.86 Million	6,801 Added 46.5%	21,427 $4.2 Million
Q4 2019 Feb 14, 2020	BUY	$146.12 - $215.82 $1.74 Million - $2.56 Million	11,884 Added 433.41%	14,626 $3.03 Million
Q3 2019 Nov 13, 2019	BUY	$130.44 - $187.64 $357,666 - $514,508	2,742 New	2,742 $419,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.